Apex Innovative Sciences
Apex Innovative Sciences, acquired by CenExel Clinical Research in 2022, operates 19 clinical research sites specializing in various medical fields and offers extensive inpatient facilities and specialized studies.
Acquisition by CenExel Clinical Research
Apex Innovative Sciences was acquired by CenExel Clinical Research on June 16, 2022. This strategic acquisition integrates Apex's extensive expertise and capabilities in clinical research with CenExel's expansive network. By joining forces, the two companies aim to enhance their capacity to deliver comprehensive clinical trials and research solutions across multiple therapeutic areas.
Clinical Research Specializations
Apex Innovative Sciences specializes in a wide range of medical fields including Psychiatry, Neurology, Pain, Human Abuse Liability, Vaccines/Immunology, Dermatology, Ethnic Bridging, Sleep, and Clinical Pharmacology/Phase I. Their broad scope of specializations allows them to conduct various types of clinical trials and research studies, making them a versatile partner in the clinical research industry.
Clinical Research Units and Inpatient Beds
Apex Innovative Sciences operates 19 clinical research sites across the country, featuring over 500 inpatient beds. These facilities enable the company to conduct extensive inpatient research studies, which are crucial for various types of clinical trials, especially those requiring long-term observation and care.
Neuroimaging and EEG/ERP Analysis
Apex Innovative Sciences provides turnkey solutions for neuroimaging data acquisition and analysis. They offer specialized services in EEG/ERP-related endpoint selection, collection, and analysis. These capabilities enhance the accuracy and efficiency of their neurological and psychiatric research studies.
Ethnic Bridging Studies
Apex Innovative Sciences conducts ethnobridging studies, with a dedicated Asian Bridging Studies Unit located in Long Beach, CA. They execute trials in Japanese, Chinese, and Korean populations, supporting global drug development by ensuring the safety and efficacy of treatments across different ethnic groups. This unit specializes in studies involving healthy volunteers, human abuse potential, driving simulation, psychedelics research, and pain models.